West Family Investments, Inc. Crispr Therapeutics Ag Transaction History
West Family Investments, Inc.
- $282 Million
- Q4 2024
A detailed history of West Family Investments, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, West Family Investments, Inc. holds 35,500 shares of CRSP stock, worth $1.41 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
35,500
Previous 35,500
-0.0%
Holding current value
$1.41 Million
Previous $1.67 Million
16.25%
% of portfolio
0.49%
Previous 0.58%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
59MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$356 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$315 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$110 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$109 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.1B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....